View Post

Using single-cell sequencing to reveal processes involved in ovarian and breast cancers

In In The News by Barbara Jacoby

From: medicalxpress.com A team of researchers from Weill Cornell Medicine, the British Columbia Cancer Research Centre and Memorial Sloan Kettering Cancer Center, working with a group from the IMAXT Consortium, has used single-cell sequencing to reveal breast and ovarian cancer-related mutational processes. In their paper published in the journal Nature, the group describes how they conducted single-cell genome sequencing on …

View Post

Rare Patient Voice Research opportunity for Ovarian and Fallopian Tube Cancer patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 60 min web-assisted phone interview Please sign up at the link below to receive an email invite to the survey.  Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …

View Post

STILL OPENED: Ancora.ai: Paid Ovarian Cancer Patient Interview

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Eligibility Criteria Patients in the US living with ovarian cancer (Stage 3-4) who are willing to discuss their experiences. Study Details Stage 3-4 ovarian cancer patients and their caregivers are invited to participate in a paid study to discuss your experiences with ovarian cancer. Compensation $125 for your time, with additional compensation for an optional pre-work task Link to Sign …

View Post

Rare Patient Voice Research opportunity for Ovarian Cancer Patients.

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 25 min online online survey Please sign up at the link below to receive an email invite to the survey.  Compensation $45 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …

View Post

Ancora.ai: Paid Ovarian Cancer Patient Interview

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Eligibility Criteria Patients in the US living with ovarian cancer (Stage 3-4) who are willing to discuss their experiences. Study Details Stage 3-4 ovarian cancer patients and their caregivers are invited to participate in a paid study to discuss your experiences with ovarian cancer. Compensation $125 for your time, with additional compensation for an optional pre-work task Link to Sign …

View Post

Rare Patient Voice: Research opportunity for Ovarian Cancer patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 25 min online survey Please sign up at the link below to receive an email invite to the survey.  Compensation $45 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay …

View Post

Savvy Cooperative: People who have been diagnosed with Breast, Colon, or Ovarian Cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Eligibility Criteria: Adult who has been diagnosed with Breast, Colon, or Ovarian Cancer NOTE: Only patients with verified diagnoses will be considered US resident   Details: At home opportunity Receive: $110 USD per interview $55 USD per survey   Link: https://gigs.savvy.coop/bc-cc-oc/?r=44951 Why Sign Up? Your experiences are so valuable and important to creating better products and services, that companies …

View Post

Ancora.ai: New Jersey-Based Patients with cervical, ovarian, or uterine cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Eligibility Criteria People living in New Jersey who have had treatment for cervical, ovarian, or uterine cancer in the past 2 years. Study Details 1-hour virtual interview conducted via computer Compensation $150 Link to Sign up https://www.surveymonkey.de/r/NJ_Women Why sign up with Ancora.ai?    Participating in research is an incredible way to share your personal opinions and insights to help improve cancer …

View Post

FDA Grants Fast-Track Designation to CX-5461 in Treatment of Certain Patients with Breast or Ovarian Cancer

In In The News by Barbara Jacoby

By: Conor Killmurray From: targetedonc.com The FDA has granted a fast-track designation to the G-quadruplex stabilizer CX-5461 for BRCA1/2, PALB2, or HRD mutations in their breast or ovarian cancer. The FDA granted a fast-track designation to the first-in-class G-quadruplex stabilizer CX-5461 (Pindnarulex) for the treatment of patients with BRCA1/2, PALB2, or other homologous recombination deficiency (HRD) mutations in their breast or ovarian …

View Post

Rare Patient Voice: Ovarian or Fallopian Tube Cancer Stage III or IV Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 25 min Online Survey Compensation $45 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …